CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

9/19/2024

Neurology Minute

0:00

1:50

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.

Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496

More episodes from "Neurology Minute"

The Placebo Effect
vor 18 Stunden
1:02
Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
vor 2 Tagen
2:23
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Don't miss an episode of “Neurology Minute” and subscribe to it in the GetPodcast app.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
vor 3 Tagen
2:11
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Lab Minute - Vitamin D
11/12/2024
4:28
Dr. Stacey Clardy discusses vitamin D in this lab minute.
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading
11/11/2024
4:28
Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
11/8/2024
1:58
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
11/7/2024
2:17
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
11/6/2024
2:06
In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
11/5/2024
2:56
Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
11/4/2024
4:47
In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107

More Episodes

Get the whole world of podcasts with the free GetPodcast app.

Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.

CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Neurology Minute

More episodes from "Neurology Minute"

The Placebo Effect

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1

Lab Minute - Vitamin D

Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1

Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Interventions for the Acute Management of Migraine Episodes in Adults - Part 3